Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Evidence & Practice Previous     Next

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders

Patrick Phillips Clinical research nurse and research associate, University of Sheffield, Sheffield, England and Member of the Cochrane Nursing Care Field

Summary statement

The mission of the Cochrane Nursing Care Field (CNCF) is to improve health outcomes through increasing the use of the Cochrane Library and supporting Cochrane’s role by providing an evidence base for nurses and healthcare professionals who deliver, lead or research nursing care. The CNCF produces Cochrane Corner columns, summaries of recent nursing-care-relevant Cochrane Reviews that are regularly published in collaborating nursing-related journals. Information on the processes CNCF has developed can be accessed at: cncf.cochrane.org/evidence-transfer-program-review-summaries. This is a Cochrane review summary of: Estcourt LJ, Desborough M, Brunskill SJ et al (2016) Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. Cochrane Database of Systematic Reviews. Issue 3. CD009733. doi: 10.1002/14651858.CD009733.pub3.

Correspondence p.phillips@sheffield.ac.uk   @patphillips1867

Nursing Standard. 32, 10,41-43. doi: 10.7748/ns.2017.e11006

Received: 11 September 2017

Accepted: 11 September 2017

Published in print: 01 November 2017

Conflict Of Interest

None declared